Study of Therapy With TransMID™ Compared to Best Standard of Care in Patients With Glioblastoma Multiforme

This study has been withdrawn prior to recruitment.

( This study has been withdrawn because the drug would not meet trial criteria for efficacy )

Study NCT00083447 Information provided by Xenova Biomedix

First Received: May 24, 2004 Last Updated: January 6, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been withdrawn prior to recruitment.
Estimated Study Completion Date:	June 2007
Primary Completion Date:	March 2006 (Final data collection date for primary outcome measure)